Vestcor Inc’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Vestcor Inc’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$271K	Hold	5,623	–	–	0.01%	954
2025 Q4	$232K	Hold	5,623	–	–	0.01%	929
2025 Q3	$218K	Buy	+5,623	New	+$183K	0.01%	961
2024 Q2	–	Sell	-17,000	Closed	-$335K	–	1218
2024 Q1	$335K	Sell	17,000 -17,434	-51%	-$340K	0.01%	793
2023 Q4	$604K	Hold	34,434	–	–	0.02%	598
2023 Q3	$598K	Hold	34,434	–	–	0.02%	562
2023 Q2	$485K	Buy	34,434 +8,539	+33%	+$114K	0.02%	613
2023 Q1	$279K	Buy	+25,895	New	+$341K	0.01%	787

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Vestcor Inc's KNSA Position: Q1 2026 in Review

Vestcor Inc held its Kiniksa Pharmaceuticals (KNSA) position steady in Q1 2026 at 5,623 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #954.

Vestcor Inc first reported a position in KNSA in Q1 2023 and has held it in 8 quarters since. The position peaked at $604K in Q4 2023. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

Vestcor Inc held 5,623 shares of Kiniksa Pharmaceuticals worth $271K as of Q1 2026.
Vestcor Inc left its Kiniksa Pharmaceuticals share count unchanged in Q1 2026.
Kiniksa Pharmaceuticals made up 0.01% of Vestcor Inc's portfolio in Q1 2026, its #954 holding.
Vestcor Inc first reported a position in Kiniksa Pharmaceuticals in Q1 2023 and has held it in 8 quarters since.
Vestcor Inc's Kiniksa Pharmaceuticals position peaked at $604K in Q4 2023.
228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.